New Mountain-backed Actylis Integrates Aceto and 10 Specialty Ingredients Businesses

Actylis Acquires Pharm-Rx

October 7, 2024

Pharmaceuticals

Actylis has acquired Pharm-Rx, a Saddle Brook, New Jersey-based supplier of specialty ingredients for the vitamin, mineral and supplement (VMS), OTC and pharmaceutical markets. The deal expands Actylis' nutrition and OTC capabilities and supplier partnerships; Pharm-Rx will continue to operate under its brand and Mark Bostel will become President, Global Nutrition and OTC for Actylis. Financial terms were not disclosed.

Aceto Consolidates Acquisition of Six Specialty Manufacturers

January 26, 2022

Pharmaceuticals

Aceto has consolidated and integrated six recent manufacturing-related acquisitions — A&C, A&C Bio Buffer, Cascade Chemistry, Finar, Islechem and Syntor Fine Chemicals — to create a hybrid manufacturing/distribution model that strengthens its GMP manufacturing, R&D and supply-chain capabilities across pharmaceuticals, biopharma, vaccines, nutraceuticals, agri-science and specialty chemicals. The acquisitions expand Aceto’s global manufacturing footprint (North America, Europe and Asia), broaden its portfolio of excipients, APIs and process solutions, and improve supply-chain resilience for customers.

New Mountain Capital Acquires Aceto Chemicals Business

April 16, 2019

Manufacturing

New Mountain Capital, through an affiliate, agreed to acquire the chemicals business of ACETO Corporation (Aceto), a Port Washington, New York-based supplier and distributor of pharmaceutical ingredients and specialty chemicals. The acquisition is intended to provide Aceto with financial and strategic resources to scale capabilities, pursue organic and inorganic growth, and strengthen its position in life sciences and specialty materials markets.

Agno Pharma Acquires Actylis Eugene (Legacy Cascade Chemistry) in Eugene, Oregon

January 15, 2026

Pharmaceuticals

Agno Pharma has acquired Actylis Eugene, the legacy Cascade Chemistry manufacturing asset in Eugene, Oregon, expanding Agno's U.S. cGMP API development and manufacturing footprint. The site includes a 16,000 sq. ft. R&D lab and a newly constructed 30,000 sq. ft. GMP manufacturing facility, enhancing Agno's capabilities to support biotech and pharmaceutical clients from early-phase through commercial API production.

Arcline Investment Management Invests in Actera Ingredients

August 12, 2019

Manufacturing

Arcline Investment Management, a growth-oriented private equity firm, made a strategic growth investment in Actera Ingredients to establish a bio-actives personal care platform. The capital will support Actera’s expansion of its actives portfolio, capabilities and team to serve personal care and beauty brand customers.

Aceto Acquires A&C (A&C Bio-Buffer)

April 15, 2021

Pharmaceuticals

Aceto has acquired A&C, a global GMP manufacturer of specialty excipients, buffers and process solutions, expanding Aceto's self-manufacturing and custom product capabilities for the vaccine, cell culture and biopharmaceutical markets. The deal adds GMP manufacturing, packaging and ingredient offerings and expands Aceto's North American and European footprint; financial terms were not disclosed.